Protease-activated receptor-1 (PAR1) acts via a novel Galpha13-dishevelled axis to stabilize beta-catenin levels.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 2865281)

Published in J Biol Chem on March 11, 2010

Authors

Hagit Turm1, Myriam Maoz, Vered Katz, Yong-Jun Yin, Steffan Offermanns, Rachel Bar-Shavit

Author Affiliations

1: Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.

Articles cited by this

Rho GTPases and the actin cytoskeleton. Science (1998) 28.19

The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol (2004) 24.63

Wnt signaling and cancer. Genes Dev (2000) 18.53

Linking colorectal cancer to Wnt signaling. Cell (2000) 11.58

Thrombin signalling and protease-activated receptors. Nature (2000) 9.27

Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta (2003) 7.85

A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res (1987) 7.43

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science (2005) 5.68

Proteinase-activated receptors. Pharmacol Rev (2001) 5.02

Differential recruitment of Dishevelled provides signaling specificity in the planar cell polarity and Wingless signaling pathways. Genes Dev (1998) 4.51

Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol (1998) 3.54

The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development (2005) 3.51

GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab (2006) 3.34

Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development (2007) 3.28

The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Nat Cell Biol (2006) 3.22

DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol (1999) 3.17

The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. Nat Struct Mol Biol (2007) 3.13

Wnt signaling: complexity at the surface. J Cell Sci (2006) 3.11

Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. Mol Cell (2003) 3.06

Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol (2003) 2.86

Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development (2004) 2.84

Dishevelled: at the crossroads of divergent intracellular signaling pathways. Mech Dev (1999) 2.51

Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med (1998) 2.42

Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem (1999) 2.38

Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science (1997) 2.28

Casein kinase iepsilon in the wnt pathway: regulation of beta-catenin function. Proc Natl Acad Sci U S A (1999) 2.25

Pleckstrin's repeat performance: a novel domain in G-protein signaling? Trends Biochem Sci (1996) 2.13

Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell (2006) 2.08

Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene (2003) 1.93

Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J Cell Biol (2008) 1.89

Dynamic recruitment of axin by Dishevelled protein assemblies. J Cell Sci (2007) 1.87

Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol (2005) 1.79

Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res (2001) 1.78

G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway. Proc Natl Acad Sci U S A (2005) 1.75

Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res (2003) 1.70

beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation. J Biol Chem (2001) 1.70

Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med (2006) 1.60

Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of Gq/G11. J Biol Chem (2003) 1.57

Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled. J Biol Chem (2001) 1.57

CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene (1999) 1.57

Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1, -2, and -3. Cell Signal (2007) 1.55

The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci U S A (2006) 1.54

Wnt/Wingless signaling through beta-catenin requires the function of both LRP/Arrow and frizzled classes of receptors. BMC Cell Biol (2003) 1.54

Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J Biol Chem (1994) 1.48

A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J Biol Chem (2006) 1.47

Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc Natl Acad Sci U S A (2007) 1.46

A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells. Proc Natl Acad Sci U S A (1993) 1.45

Domains of axin and disheveled required for interaction and function in wnt signaling. Biochem Biophys Res Commun (2000) 1.43

Dishevelled: a mobile scaffold catalyzing development. Curr Top Dev Biol (2006) 1.43

Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene (2008) 1.42

The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol Cell Biol (2005) 1.39

Human dishevelled genes constitute a DHR-containing multigene family. Genomics (1997) 1.31

Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product. Mol Cell Biol (1993) 1.28

Essential role for Galpha13 in endothelial cells during embryonic development. Proc Natl Acad Sci U S A (2005) 1.22

Characterization of function of three domains in dishevelled-1: DEP domain is responsible for membrane translocation of dishevelled-1. Cell Res (2004) 1.19

Axin contains three separable domains that confer intramolecular, homodimeric, and heterodimeric interactions involved in distinct functions. J Biol Chem (2004) 1.16

Ccd1, a novel protein with a DIX domain, is a positive regulator in the Wnt signaling during zebrafish neural patterning. Curr Biol (2003) 1.15

Thrombin protease-activated receptor-1 signals through Gq- and G13-initiated MAPK cascades regulating c-Jun expression to induce cell transformation. J Biol Chem (2003) 1.13

FP prostanoid receptor activation of a T-cell factor/beta -catenin signaling pathway. J Biol Chem (2001) 1.11

Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability. Oncogene (1996) 1.09

G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. Proc Natl Acad Sci U S A (2000) 1.05

cDNA characterization and chromosomal mapping of two human homologues of the Drosophila dishevelled polarity gene. Hum Mol Genet (1996) 1.02

The trimeric G protein Go inflicts a double impact on axin in the Wnt/frizzled signaling pathway. Dev Dyn (2010) 0.96

Up-regulation and overproduction of DVL-1, the human counterpart of the Drosophila dishevelled gene, in cervical squamous cell carcinoma. Oncol Rep (2003) 0.95

Distinct regions of the cadherin cytoplasmic domain are essential for functional interaction with Galpha 12 and beta-catenin. J Biol Chem (2001) 0.94

Beta-catenin, cancer, and G proteins: not just for frizzleds anymore. Sci STKE (2005) 0.94

Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization. Cancer Res (2006) 0.91

Upregulation and overexpression of DVL1, the human counterpart of the Drosophila dishevelled gene, in prostate cancer. Tumori (2006) 0.91

RGS19 regulates Wnt-beta-catenin signaling through inactivation of Galpha(o). J Cell Sci (2007) 0.87

Transient overexpression of murine dishevelled genes results in apoptotic cell death. Exp Cell Res (1999) 0.84

Dishevelled-2 maps to human chromosome 17 and distal to Wnt3a and vestigial tail (vt) on mouse chromosome 11. Mamm Genome (1996) 0.78

Articles by these authors

Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer (2006) 1.42

Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int J Cancer (2005) 1.20

Human alpha-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Blood (2002) 1.16

Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB J (2003) 1.14

Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness. Arterioscler Thromb Vasc Biol (2003) 1.02

Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression. Mol Cancer Res (2007) 1.01

Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer. Cancer Res (2007) 0.95

PAR1 plays a role in epithelial malignancies: transcriptional regulation and novel signaling pathway. IUBMB Life (2011) 0.91

Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization. Cancer Res (2006) 0.91

The pattern of expression of protease-activated receptors (PARs) during early trophoblast development. J Pathol (2003) 0.89

Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin stabilization. J Cell Physiol (2009) 0.87

Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin. Gynecol Oncol (2002) 0.86

Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance. PLoS One (2010) 0.86

Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol Biochem Behav (2004) 0.83

Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer. Cell Mol Life Sci (2013) 0.83

The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma. Gynecol Oncol (2006) 0.82

Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen. FASEB J (2012) 0.81

Identification of a novel functional androgen response element within hPar1 promoter: implications to prostate cancer progression. FASEB J (2005) 0.81

Association study of protease activated receptor 1 gene polymorphisms and adverse pregnancy outcomes: results of a pilot study in Israel. Am J Med Genet A (2007) 0.77

Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block. Brain (2008) 0.76

DVL as a scaffold protein capturing classical GPCRs. Commun Integr Biol (2010) 0.75

Par genes: molecular probes to pathological assessment in breast cancer progression. Patholog Res Int (2011) 0.75